Page N, Lemeille S, Vincenti I, Klimek B, Mariotte A, Wagner I, et al. Persistence of self-reactive CD8+ T cells in the CNS requires TOX-dependent chromatin remodeling. Nat Commun. 2021;12:1009 pubmed publisher

Hamdan F, Feodoroff M, Russo S, Fusciello M, Feola S, Chiaro J, et al. Controlled release of enhanced cross-hybrid IgGA Fc PD-L1 inhibitors using oncolytic adenoviruses. Mol Ther Oncolytics. 2023;28:264-276 pubmed publisher

L xf3 pez Sanz C, S xe1 nchez Mart xed nez E, Jim xe9 nez Saiz R. Protocol to desensitize human and murine mast cells after polyclonal IgE sensitization. STAR Protoc. 2022;3:101755 pubmed publisher

Li Y, Lei Z, Ritzel R, He J, Li H, Choi H, et al. Impairment of autophagy after spinal cord injury potentiates neuroinflammation and motor function deficit in mice. Theranostics. 2022;12:5364-5388 pubmed publisher

Evgin L, Kottke T, Tonne J, Thompson J, Huff A, van Vloten J, et al. Oncolytic virus-mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in mice. Sci Transl Med. 2022;14:eabn2231 pubmed publisher

Hamdan F, Ylösmäki E, Chiaro J, Giannoula Y, Long M, Fusciello M, et al. Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids. J Immunother Cancer. 2021;9: pubmed publisher

Park S, Oh J, Park D, Zhang H, Noh M, Kim Y, et al. CU06-1004-Induced Vascular Normalization Improves Immunotherapy by Modulating Tumor Microenvironment via Cytotoxic T Cells. Front Immunol. 2020;11:620166 pubmed publisher

Lind L, Svensson A, Thörn K, Krzyzowska M, Eriksson K. CD8+ T cells in the central nervous system of mice with herpes simplex infection are highly activated and express high levels of CCR5 and CXCR3. J Neurovirol. 2021;27:145-153 pubmed publisher

Kim C, Jadhav R, Gustafson C, Smithey M, Hirsch A, Uhrlaub J, et al. Defects in Antiviral T Cell Responses Inflicted by Aging-Associated miR-181a Deficiency. Cell Rep. 2019;29:2202-2216.e5 pubmed publisher

Zhang X, Wang P, Chen T, Yan W, Guan X, Shen G, et al. Kctd9 Deficiency Impairs Natural Killer Cell Development and Effector Function. Front Immunol. 2019;10:744 pubmed publisher

van Vloten J, Santry L, McAusland T, Karimi K, McFadden G, Petrik J, et al. Quantifying Antigen-Specific T Cell Responses When Using Antigen-Agnostic Immunotherapies. Mol Ther Methods Clin Dev. 2019;13:154-166 pubmed publisher